Key Strengths

• Vectors used with AdVac^® technology share the advantages of the commonly used adenoviral vectors such as: scalable RCA-free production, high yields and the ability to mediate a strong T-cell immune response. 

• The AdVac^® technology, in contrast to commonly used adenoviral vectors, can circumvent pre-existing immunity offering accurate dose control of the vaccines based on this technology. 
  
  
• AdVac^® vectors can be engineered to contain small genetic fragments of different viruses, parasites and bacteria. This makes the development of a wide variety of novel vaccines against a broad range of dangerous human pathogens possible. 

• AdVac^® vectors can be produced on the PER.C6^® cell line, which supports the cost-effective production of safe vaccines in industrial-scale quantities for vaccines for both the developed and non-developed world.